WallStreetZenWallStreetZen

NASDAQ: PBM
Psyence Biomedical Ltd Stock Ownership - Who owns Psyence Biomedical?

Insider buying vs selling

Have Psyence Biomedical Ltd insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when PBM insiders and whales buy or sell their stock.

PBM Shareholders

What type of owners hold Psyence Biomedical Ltd stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Marc Gregory Balkin55.67%7,455,000$1.42MInsider
Newcourt Spac Sponsor LLC6.87%920,000$175.72kInsider
Polar Asset Management Partners Inc3.96%530,000$101.23kInsider
Advisorshares Investments LLC3.46%463,042$88.44kInstitution
Cantor Fitzgerald L P2.52%337,000$64.37kInstitution
Ubs Group Ag0.17%22,885$4.37kInstitution
Morgan Stanley0.15%20,000$3.82kInstitution
Clear Street LLC0.15%20,000$3.82kInstitution
Hrt Financial LP0.13%18,077$3.45kInstitution
Virtu Financial LLC0.11%14,899$2.85kInstitution

1 of 2

PBM vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PBM6.77%66.53%
BPTH0.79%99.21%
SCPX0.61%99.39%
PHIO0.16%99.84%Net Buying
SXTP8.29%91.71%Net Buying

Psyence Biomedical Stock Ownership FAQ

Who owns Psyence Biomedical?

Psyence Biomedical (NASDAQ: PBM) is owned by 6.77% institutional shareholders, 66.53% Psyence Biomedical insiders, and 26.70% retail investors. Marc Gregory Balkin is the largest individual Psyence Biomedical shareholder, owning 7.46M shares representing 55.67% of the company. Marc Gregory Balkin's Psyence Biomedical shares are currently valued at $1.41M.

If you're new to stock investing, here's how to buy Psyence Biomedical stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.